股市必读：蓝帆医疗（002382）1月8日主力资金净流出285.43万元

Group 1 - The core point of the news is that Bluestar Medical (002382) is proposing to lower the conversion price of its convertible bonds due to the stock price being below the required threshold for a certain period [1][2][4] - On January 8, 2026, Bluestar Medical's stock closed at 5.86 yuan, with a 1.21% increase, a turnover rate of 1.43%, a trading volume of 142,500 shares, and a transaction amount of 83.22 million yuan [1] - The company reported a net outflow of 285.43 million yuan from institutional investors and a net inflow of 432.3 million yuan from retail investors on January 8 [1][4] Group 2 - The Board of Directors of Bluestar Medical approved a proposal to lower the conversion price of the "Bluestar Convertible Bonds" due to the stock price being below 85% of the conversion price for at least 15 out of the last 30 trading days [1][2] - The proposed adjustment to the conversion price will be submitted for approval at the first extraordinary general meeting of shareholders in 2026, scheduled for January 26, 2026 [2] - The adjustment must be approved by more than two-thirds of the voting rights held by shareholders present at the meeting, and bondholders must abstain from voting [2]